Los Angeles Biotechnology Network
  • Events
    • Categories
    • Locations
    • My Bookings
    • Tags
  • Life Science News, Jobs, Events
News Ticker
  • [ March 4, 2021 ] STAT+: Amgen spends $1.9 billion on Five Prime, eyeing an expansion in Asia News
  • [ March 4, 2021 ] Amgen snaps up cancer drug player Five Prime, adding PhIII-ready FGFR2b drug in $2B M&A play News
  • [ March 4, 2021 ] Research Lab Tech I – USC – Los Angeles, CA Jobs
  • [ March 4, 2021 ] Research Lab Technician II – USC – Los Angeles, CA Jobs
  • [ March 4, 2021 ] Research Lab Technician II – USC – Los Angeles, CA Jobs
HomeNewsPuma Biotechnology to Present at the B. Riley Oncology Investor Conference

Puma Biotechnology to Present at the B. Riley Oncology Investor Conference

January 19, 2021 Los Angeles Biotechnology Network News News Comments Off on Puma Biotechnology to Present at the B. Riley Oncology Investor Conference
LOS ANGELES--(BUSINESS WIRE)--Alan Auerbach, CEO and President of Puma Biotechnology, will present a company update at the B. Riley Oncology Investor Conference on Jan. 21.

Click to view original post

Previous

 ImmunityBio Announces Phase I Trial of COVID-19 Vaccine Candidate in South Africa as New Variants of SARS-CoV-2 Spread

Next

Eli Lilly tees up discovery pact worth more than $1.6B with Merus for T cell-focused bispecific antibodies

Recent Posts

  • STAT+: Amgen spends $1.9 billion on Five Prime, eyeing an expansion in Asia
  • Amgen snaps up cancer drug player Five Prime, adding PhIII-ready FGFR2b drug in $2B M&A play
  • Research Lab Tech I – USC – Los Angeles, CA
  • Research Lab Technician II – USC – Los Angeles, CA
  • Research Lab Technician II – USC – Los Angeles, CA

Copyright © 2021 | MH Magazine WordPress Theme by MH Themes